PRADAXA 20 mg, coated granules 60 sachets
Brand page: Pradaxa (dabigatran etexilate) — all forms and strengths in France
Active ingredients: DABIGATRAN ÉTEXILATE, MÉSILATE DE DABIGATRAN ÉTEXILATE
Commercialized according to BDPMDispensing in France: Prescription only
Coated granules60 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PRADAXA 20 mg, granulés enrobés
- Pharmaceutical form
- granulés enrobé
- Route of administration
- orale
- Presentation description
- 60 sachet(s) polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) aluminium
- Marketing authorisation holder
- BOEHRINGER INGELHEIM INTERNATIONAL
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 5 Dec 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65070765CIP73022391CIP133400930223918Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DABIGATRAN ÉTEXILATEgranulés | 20 mg · un sachet | FT |
| MÉSILATE DE DABIGATRAN ÉTEXILATEgranulés | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.